You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Soluble L-selectin, sCD62L, SPARC, Imatinib, CML

Showing 1 - 25 of 4,808
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

Completed
  • Chronic Myeloid Leukemia
  • ELISA kit
  • Tanta, Egypt
    Tanta University
May 18, 2022

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Los Angeles, California
  • +31 more
Nov 11, 2021

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
Has Results
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Developmental Endothelial Locus-1, Platelet Count, and Soluble

Not yet recruiting
  • Overweight and Obesity
  • Platelet count
  • +2 more
  • Aswan, Egypt
    Aswan University Hospital
May 17, 2023

Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

Completed
  • Chronic Myeloid Leukaemia
  • Rionero in Vulture, Potenza, Italy
  • +32 more
Oct 24, 2022

Effect of Pharmacogenetics on Imatinib Plasma Level and Response

Active, not recruiting
  • Chronic Myeloid Leukemia
  • PCR
  • HPLC-UV
  • Assiut, Egypt
    South Egypt Cancer Institute
Aug 6, 2022

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

Completed
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Angers, France
  • +9 more
Aug 17, 2022

New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Recruiting
  • Validity and Safety
    • Guangzhou, Guangdong, China
      NanfangH
    Apr 9, 2022

    Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

    Recruiting
    • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
    • Longmont, Colorado
    • +128 more
    Aug 1, 2022

    Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

    Active, not recruiting
    Has Results
    • Chronic Myeloid Leukemia
    • Los Angeles, California
    • +61 more
    Mar 17, 2022

    Flumatinib, Chronic Myeloid Leukemia, Chronic Phase, Imatinib Trial in Shenzhen (Flumatinib)

    Recruiting
    • Flumatinib
    • +2 more
    • Shenzhen, Guangdong, China
      The Second People's Hospital of Shenzhen
    Mar 15, 2022

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
    • (no location specified)
    Jun 7, 2022

    Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

    Recruiting
    • Chronic Myeloid Leukemia in Chronic Phase
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Beirut, Lebanon
      American University of Beirut Medical Center
    Feb 14, 2022

    Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

    Recruiting
    • Philadelphia Chromosome Positive CML
    • BCR-ABL Positive Chronic Myelogenous Leukemia
    • Amiens, France
    • +27 more
    Dec 9, 2021

    Transfusion of Whole Blood in Acute Bleeding

    Enrolling by invitation
    • Blood Transfusion
    • Acute Bleeding
    • Whole blood transfusion
    • Örebro, Sweden
      Örebro University
    Aug 24, 2023

    CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

    Not yet recruiting
    • CML, Chronic Phase
    • Harbin, Heilongjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    May 5, 2022

    Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

    Completed
    • Chronic Myeloid Leukemia
    • Ascoli Piceno, Italy
    • +21 more
    Jan 3, 2022

    Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, China
      Peking University People's Hospital(北京大学人民医院)
    Jan 3, 2022

    Endothelial Function in HIV/HCV Coinfected Subjects

    Completed
    Has Results
    • HIV
    • Hepatitis C
      • Los Angeles, California
        UCLA CARE Center
      Dec 20, 2021

      Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

      Completed
      Has Results
      • Chronic Myelomonocytic Leukemia
      • +4 more
      • Imatinib Mesylate (Gleevec)
      • Houston, Texas
        UT MD Anderson Cancer Center
      Dec 7, 2021